EMA
- Status: approved
Famtozinameran 5 to 11 Years of age (famtozinameran-5-to-11-years-of-age) regulatory status in European Union.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA has authorised it.
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.